Примери за използване на Candidate for substitution на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Renewal of the approval of the active substance as a candidate for substitution.
Prosulfuron was also found to be a candidate for substitution pursuant to Article 24 of Regulation(EC) No 1107/2009.
It is identified if the product contains any active substance which is approved as a candidate for substitution.
An active substance will be considered as a candidate for substitution if any of the following criteria are met.
It is more difficult to obtain a product authorisation if an active substance contained in the product is identified as a candidate for substitution.
An active substance shall be considered a candidate for substitution if any of the following conditions are met.
If an active substance is approved for use although it fulfils one or more of the exclusion criteria,it is considered as a candidate for substitution.
The approval of the active substance esfenvalerate, as a candidate for substitution, is renewed as set out in Annex I.
Azoxystrobin therefore meets the conditions set out in point(d)of Article 10(1) of Regulation(EU) No 528/2012 and should be considered a candidate for substitution.
The Commission however considers that esfenvalerate is a candidate for substitution pursuant to Article 24 of Regulation(EC) No 1107/2009.
Candidate for substitution: Active substances with certain properties for which EU countries are required to evaluate if they can be replaced(substituted) by other adequate solutions(chemical and non-chemical).
An active substance shall be approved as a candidate for substitution pursuant to Article 24 where any of the following conditions are met.
A comparative assessment shall be performed by Member States when evaluating an application for authorisation for a plant protection product containing an active substance approved as a candidate for substitution.
Cyphenothrin is considered a candidate for substitution in accordance with point(d) of Article 10(1) of Regulation(EU) No 528/2012.
Pursuant to Article 10(4) of that Regulation, the approval of an active substance that is considered as a candidate for substitution should be for a period not exceeding 7 years.
A substance can also be a candidate for substitution if it meets certain other criteria specified in the Biocidal Products Regulation.
Fee reductions for applications for the approval, renewal of approval, inclusion in Annex I of active substances if the active substance manufacturer is an SME established in the Union,except where the active substance is a candidate for substitution.
A product containing an active substance that is candidate for substitution is subject to comparative assessment prior to its approval.
Fee reductions for applications for the granting and renewal of Union authorisationof biocidal products or biocidal product families, if the prospective authorisation holder is an SME established in the Union,except where the product contains an active substance which is a candidate for substitution.
In addition, biocidal products containing an active substance that is a candidate for substitution, will undergo a comparative assessment before authorisation.
When an active substance is a candidate for substitution, biocidal products containing that active substance will become subject to a comparative assessment at the time of authorisation and will only be authorised if there are no better alternatives.
It should be noted that the companies can benefit from reduced fees only when the active substance is not a candidate for substitution and when the product does not contain an active substance which is a candidate for substitution.
Where an active substance is identified as a candidate for substitution, the Member State should carry out a comparative assessment to check whether other authorised biocidal products, non-chemical control or prevention methods that present a significantly lower overall risk for human health, animal health and the environment are available.
An active substance complying with the criteria provided for in Article 4 shall be approved,for a period not exceeding seven years, as a candidate for substitution if it meets one or more of the additional criteria laid down in point 4 of Annex II.
In addition, the use of products containing warfarin raises concerns in relation to instances of primary and secondary poisoning, even where restrictive risk management measures are applied andtherefore warfarin also satisfies the criterion to be a candidate for substitution in accordance with Article 10(1)(e) of that Regulation.
By way of derogation from paragraph 1,a plant protection product containing a candidate for substitution shall be authorised without comparative assessment in cases where it is necessary to acquire experience first through using that product in practice.
By way of derogation from Article 36(2)Member States may in exceptional cases also apply the provisions of paragraph 1 of this Article when evaluating an application for authorisation of a plant protection product not containing a candidate for substitution or a low-risk active substance, if a non-chemical control or prevention method exists for the same use and it is in general use in that Member State.
By way of derogation from paragraph 1,a plant protection product containing a candidate for substitution shall be authorised without comparative assessment in cases where it is necessary to acquire experience first through using that product in practice.
Since harmonised classification is a key element in the exclusion criteria andtherefore for the assessment of whether an active substance is a candidate for substitution, the ECHA secretariat will aim to ensure cooperation between the Biocidal Products Committee(BPC) and the Risk Assessment Committee(RAC).